Aurinia Pharmaceuticals Inc (AUPH)

[cervelo]

i must respectively disagree. we were almost at 17.00 covid or no covid.
We dropped because of managements dilution of the stock and have yet to recover because of it.
The market sees dilution for what it is and when the company continues to do it the market believes is more after a money grab rather than feel 100% sure of the product that is being produced.

Adding 200 million to the coffers when it is not needed for a few years in the future make me often wonder it management is hinging on FDA refusal.

Again as running my own company for over 27 years this is not how quality managers run things.

As a private company I always looked out for my employees, as a public company like auph management has a responsibility to shareholders.
continued dilution is anything but positive for shareholders.